まとめ
ウィルチョウ (Virchow) とは,ヴィルチョウ (Virchow) とは,ヴィルチョウ (Virchow) とは,ヴィルチョウ (Virchow) とは
科学分野:
- 血液学 ヘマトロジ
- 血管生物学 血管生物学
- トロンボシス研究研究
背景:
- 血栓の理解は,血管損傷,血流の変化,高凝固性というVirchowのトライアードに基づいています.
- 凝固性の高い状態は,凝固因子,血小板数,活性化凝固因子,または質的変化の増加を含む.
- アンチトロンビンIIIやタンパク質Cのような天然の抗凝固剤の欠乏は,再発性血栓塞栓症と関連しています.
研究 の 目的:
- ハイパー凝固性の多面的性質と血栓形成におけるその役割を探求する.
- 凝固因子レベル,血小板機能,抗凝固剤の欠乏を血栓形成リスクと関連付ける証拠をレビューする.
- 血栓性傾向における繊維分解の障害の影響を検証する.
主な方法:
- トロンボシスに関する既存の文献と確立された理論のレビュー.
- 血液学的パラメータと血栓性傾向の間の相関の分析.
- 遺伝的凝固障害を有する患者からの臨床的証拠の検討.
主要な成果:
- 凝固因子と血小板数の増加は,血栓形成のリスクと相関することがあります.
- 活性化凝固因子のレベルが高まり,血液の質的変化が,血栓形成に寄与する可能性がある.
- アンチトロンビンIIIとタンパク質Cの遺伝的欠乏は,再発性血栓塞栓症と強く関連しています.
結論:
- 凝固因子や天然の抗凝固剤を含む血液組成の変化は,血栓形成に重要な役割を果たします.
- 繊維分解の障害は,また,個人を血栓性イベントに誘発することがあります.
- 終身定着性疾患を持つ個人が,なぜ血栓性エピソードが少ないのかを説明するために,さらなる研究が必要である.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...